Previous 10 | Next 10 |
2024-03-19 01:46:56 ET Summary FY2023: TransMedics' revenues up 159%, profitability improves, breakeven could be on the horizon. Potential 2x top-line growth medium term in the U.S. alone. TransMedics' Organ Care System (OCS) could drive transplant volumes by expanding the donor p...
2024-03-12 14:14:40 ET Summary TransMedics Group is transforming the organ transplant landscape with its expansive transplant solutions. The company has a proven technology, FDA approved, making it a rare early commercial-stage investment opportunity. TransMedics has led to do...
2024-03-01 08:45:00 ET Tech giant Nvidia has been one of the hottest stocks over the past couple of years, with its shares more than doubling since 2022. But technology isn't the only place where investors can find excellent investments. In fact, three healthcare stocks that h...
2024-02-27 09:06:36 ET DENVER, Colo., Feb 27, 2024 ( 247marketnews.com )- The following companies are mentioned; Codexis (NASDAQ: CDXS ), Kraig Biocraft Laboratories (OTCQB: KBLB ), Janux Therapeutics (NASDAQ: JANX ), TransMedics Group (NASDAQ: TMDX ), and Viking Therape...
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire ANDOVER, Mass. , Feb. 26, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy f...
SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 uniQure N.V. (QURE) is expected to report $-1.54 for Q4 2023 Albany International Corporation (AIN) is expected to report $0.84 for Q4 2023 I...
TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024 PR Newswire ANDOVER, Mass. , Feb. 12, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transformin...
2024-02-08 17:01:33 ET Summary TransMedics Group, Inc. has successfully developed the Organ Care System to improve organ transplantation success rates. Wider approvals for more indications have driven spectacular growth in recent years. After concerns about M&A activity, T...
2024-02-07 10:28:09 ET Summary TransMedics has a dominant market position in the organ transplant market due to its revolutionary Organ Care System product, which helps organs survive longer, enabling significantly greater reach. At 15x TTM P/S and 9x NTM P/S, TransMedics stock is...
2024-02-05 10:45:00 ET Summary MoneyShow presents top investment ideas for 2024 from their contributors. This year’s edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth stocks, as well as ETF recommendations tha...
News, Short Squeeze, Breakout and More Instantly...
TransMedics Group Inc. Company Name:
TMDX Stock Symbol:
NYSE Market:
2024-05-14 13:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve opted to ke...
Tuesday, organ transplant-medical device firm TransMedics Group Inc (NASDAQ:TMDX) reported first-quarter EPS of 35 cents, a turnaround from an EP...